Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For Paulson to make money CYDY has to generate revenue to pay them. They need CYDY to get approvals and stay in business.
That extra 11 million they gave to CYDY would be really weird if they were planning to close shop. Why bother sending money, getting Kelly to step down and plunking a Paulson affilate on the board to right the ship?
Even if Paulson some how compelled the sale of CYDY at that point CYDY would have to have 2 approvals under it's belt to be a net win. That means a stout pay off.
More likely Paulson lets CYDY roll on and pay them for a very long time.
No idea. The candidate pool is way too big.
That would be something to like. 2 Paulson affiliates means they are basically going to run the show to get the approvals done. CYDY pays back Paulson overtime from revenues. Paulson doesn't have to do a write down, CYDY gets to keep operating.
So if CYDY's comp package for the new CEO is performance incentive heavy, you can bet that's a Paulson set thing as apart of the December funding CYDY just received.
So external candidate good. External candidate with Paulson ties better.
New CEO comp will be something to look at. If it's a lot of performance based incentives over straight salary and usual options, that is another tell.
Next CEO is the signpost for the company's future. I'd look at where they came from, prior dealings, connections to current board and what they did with their last companies.
Based on the announced Paulson funding and the new BOD member Tanya, also Paulson, I have some guesses.
Basically if the new CEO is some how involved with Paulson, it's going to be Paulson running the show.
Paulson funding plus Paulson Board member?
If the new CEO has a connection, it's more than coincidence.
Same reason after firing an abysmal Head Coach you don't put his Assistant in the top spot. You go fresh, new, and signal business as usual is over. It's the exact move the BOD wouldn't do. Best guess.
The next CEO is make or break that is certain.
Sell the drug and close the company? What does the company have that makes worth gutting it. No special equipment, no workforce, no other assets, no land the office is rented. Have to break a lease on top of that.
Package the whole thing up for a buyout. Just enough to take a profit. 10 to 20 bucks. It would have to be HIV or NASH to do it. So not the win anyone expects.
But this is all hinging on who the new CEO is and if there is a Paulson connection. An internal candidate would just spell absolute doom.
Other two things then if this is to work is a shake up at the board, and some sort of new financing deal or something. Something that would signal the company will essentially be frog marched by Paulson to getting a result.
I really wasn't paying attention this new person and didn't see the connections.
Okay so check this out.
CYDY filing:
https://www.cytodyn.com/investors/sec-filings/all-sec-filings
Ms. Urbach is currently Partner/Head of Family Office for Eagle Bay Advisors, which provides family office and investment advisory services, and also provides corporate governance and corporate finance advice to Dynepic, Inc., which provides an integrated platform to power immersive training programs for companies and U.S. military forces.
Tanya D. Urbach is an affiliate expert for the Bates Group....
The deification of Nader and things being the FDA's fault. I suspect until there is news, it will be much the same. Then news will tip the scales.
Any chance Paulson is that dark money?
If Nader was basically doing this all by himself. Handing the communications and telling the board one thing, then Nader alone probably goes down.
If the company picks a CEO that has an interesting connection to Paulson, Bates Group or Tanya then there is a good chance of daylight.
If it's an internal choice, not good.
CDC and FDA. Wouldn't doubt a connection.
That would explain the shell game with the other companies. If they shift the IP to another company while CYDY holds the debt it sort of turns CYDY into a poison pill.
CYDY goes under. New company free of DOJ and SEC can fundraise. So the board inked this deal. Which raises a new question:
Did the board plan to oust Nader for a while now. If so was it apart of the DOJ and SEC. They may just want an example, Nader, and let CYDY either take a fine and dissolve or CYDY gets free and clear to issue it's shares provided Nader goes down with the company cooperating.
Now none of the board expect one person would know exactly how to do that...
The Board has elected Tanya Durkee Urbach, an independent director who has experience in corporate governance, corporate finance, business growth and securities litigation, compliance and regulatory issues, as Chairman of the Board.
Two ways the new CEO could fix things either one depends on an approval.
Either Nash is like 40/60 or 50/50 deal with some else, or HIV. One of the first approvals has to be a semi-sacrificial lamb for extra funds. COVID may be done by 2025, but cancer with the right team would more than make up for it.
Unless miracle fundraising occurs. Then different.
But if Scott Kelly or another internal candidate shows up. Game over.
That's doesn't have a list of hospitals so no idea.
MY REASON FOR BEING MAD AT NADER
Nader cost a lot of people a lot of money. Some of us saw a lot of promise in the drug. A lot of us say financial daylight when the stock hit 10 bucks.
Then it got hit. Then Nader promised the HIV BLA. A lot of people assumed HIV was bullet proof. If it had been properly put together and submitted, it would have been a slam dunk.
It was eye opening when that email from Nader to Amarex was released. HIV is lke 16 billion dollar market. Gilead would have fought a losing battle because HIV wise, their drugs are dated.
Imagine having 30K shares, relying on Nader's reports and based on what you know at the time that the shares should have been at a minimum of 20 on HIV approval up to 50 on a blue sky shoot the moon kind of day.
I don't think I will ever stop being angry at Nader.
Maybe if the new CEO is good, maybe I'll risk something again. I just hope they pick well.
List of all the hospitals using Remedsivir:
https://dph.georgia.gov/sites/dph.georgia.gov/files/2020-05/remdesivir.jpg
No looks like a different document all together.
At this point I think the entire BOD needs to be removed. I thought the problem was just Nader and Kelly with some nodding heads on the board. I am now taking the position the board of directors has been complicit in fraud.
He and the board need to go. I believe they were complicit in fraud.
Found This Old List Of Paid Promotoers For CYDY:
https://sec.report/otc/financial-report/200630/OTCQB-Certification.pdf
One that stands out is Mike Sheikh who writes for Zerohedge and runs equally shady Falcon Strategic Research. So tapped by CYDY to puff the company. Connected to Nader and Mulholland.
Excellent find Saltz. Probably more relevant now than ever.
Remdesivir. You mean the drug that went through testing. Had listed side effects but showed clinical significance? That received it's EUA because it was first across the finish line when there were no other drugs available?
The very same Remdesivir that also set the low bar for other drugs to receive their EUAs. The bar so low you have to trip on it to fail, and yet CYDY broke it's neck on that low bar?
That's "Nuff said." PPPFFFTTTT lol.
Beyond just being a major lapse in journalistic integrity, makes me wonder if it is apart of an illegal stock pumping scheme. So many aliases and lies.
Historical examples that for some reasons went unlisted....
The FDA has made errors, any agency over it's lifetime will. I can't think of a single organization, business, club or charity that hasn't made a mistake.
So let's look at what happens when the FDA makes a mistake and say CYDY makes one.
The FDA makes an egregious error. There is an investigation and hearing. If people need to be fired it happens. Actions and policies are reviewed and improved to have better performance.
CYDY makes error after error. Nader got away with riding the company into the ground. He went from lying to outright fraud because there was no actual system of checks and balances on him.
Unlike the inner workings of CYDY. We have the advantage of transparency with the regulatory and approval process of the FDA. We know the trial results, and that those results did not meet FDA requirements.
No mystery or grand conspiracy. CYDY sucked, and it's drug trials sucked, so it got what any rational person would expect which was a rejection.
CYDY had no transparency. Easily evidenced by the HIV BLA fraud committed by Nader. The lies he told investors. In the end CYDY was the rotten apple in the barrel. None of the hard core Naderities want to admit it.
I think I will have that great weekend, thank you.
No it's not. It just said no to a drug that a people had a financial interest in. Those people are just angry they missed a payday. The rules are only unfair when someone that demanded to win loses.
I would expect speculation to ramp in Q3 and Q4.
No one has to really do much to point out CYDY failed it's trials, had bad management, did not meet end points, failed to show statistical significance, debunk rumors, lies and pumping tactics.
For example:
it did not meet its endpoint but I think saving 31% above the SOC with patients that are extremely sick is effective.
CYDY has yet to put up the 6.5 million dollar bond. That timeline is ticking.
Also from the latest court records we can see motions cancelled and CYDY's counsel have left the case.
https://www.pacermonitor.com/public/case/42127811/CytoDyn,_Inc_v_Amarex_Clinical_Research,_LLC_et_al
Meanwhile the DOJ and SEC continues it's investigation into Nader and pals.
MISINFORMATION KILLS: THE FAMOUS ZEROHEDGE "HERO MOM" STORY
Many will recall the famous article written by Chessmaster over on ZeroHedge. It involved someone withholding the standard of care from their child in favor of Leronlimab. They some how managed to get the drug through Right To Try despite not going through the standard of care. Many miraculous and contradictory claims were made in the article.
Well behold that article was pulled:
https://www.zerohedge.com/news/2021-08-12/leronlimab-anecdotes-patients-perspective-beating-system
THAT'S RIGHT, THE AUTHOR OR SITE DELETED THE BODY OF THE WORK BECAUSE IT WAS FALSE, BUPKIS, AND A LIABILITY.
Just in case you are wondering if maybe older articles just somehow disappear. Here is an older gem by the same misinformation peddler about CYDY and it's unproven drug.
https://www.zerohedge.com/news/2021-07-08/connecting-dots-cytodyns-valuation
HERE WE SEE AN ARTICLE IN FULL. OLDER THAN THE PULLED ARTICLE. SO NO QUESTION THE ARTICLE GOT PULLED OVER FACTUAL PROBLEMS.
Misinformation kills. This article was held up as a major piece of evidence in support of CYDY and Leronlimab. It has since been pulled. It is important to note that CYDY and it's various communications are under investigation by the DOJ and SEC. Is there a connection between the investigations and the article going down???
MYTH BUSTING: CYDY'S "BIG LIE"
But even at 28 days where there was no more leronlimab in the system , mortality benefit was 31% ABOVE all SOC drugs..
Yes here we are in the critical patients , leronlimab without one serious side effect , with 82% mortality benefits above ALL THESE TOXIC SOC drugs with very minimal efficacy.
Even with sabotaged by FDA study , with only 2 injections of leronlimab at 0 and 7 days, results are very clear.
At 7 days there was 78% mortality benefit ABOVE ALL SOC drugs ...
At 14 days , it was 82% ,
82 % mortality benefit , how much smaller the death number will be.
There is a reason for almost 1 M Americans death in the last 2 years , and most of people died in the last 1 year , the more SOC drugs are use , the more are dying...
CYDY's Q10 shows it is the target. Both Nader and Left have criminal records. Left being looked into is no surprise, just as it should be no surprise Nader and CYDY are being looked into.
The assumption one is the target and not the other is naïve. I have no doubt the DOJ and SEC would like to clean house on scammers like Nader and Left.
This is what it looks like when large investment firms take your company seriously:
https://d18rn0p25nwr6d.cloudfront.net/CIK-0001293310/a8107b95-823f-4bf0-ada3-24eacc0a1ec5.pdf
That's a 13G, it has to be filed any time a 5% interest in a company is hit.
CYDY doesn't have Black Rock knocking on it's door. Nor do we see institutions really buying up the stock.
https://whalewisdom.com/stock/cydy
Nothing approaching that. And here is CYDY executives cashing out:
http://openinsider.com/screener?s=CYDY&o=&pl=&ph=&ll=&lh=&fd=1461&fdr=&td=0&tdr=&fdlyl=&fdlyh=&daysago=&xp=1&xs=1&vl=&vh=&ocl=&och=&sic1=-1&sicl=100&sich=9999&grp=0&nfl=&nfh=&nil=&nih=&nol=&noh=&v2l=&v2h=&oc2l=&oc2h=&sortcol=0&cnt=100&page=1
You'll notice Nader, Kelly, and Mulholland pretty much made a run on the bank.
So new CEO will be critical to the company and ousting Kelly and the board probably a top priority.
Fairly Interesting:
https://fintel.io/so/us/hgen
https://whalewisdom.com/stock/kbio
http://openinsider.com/screener?s=HGEN&o=&pl=&ph=&ll=&lh=&fd=1461&fdr=&td=0&tdr=&fdlyl=&fdlyh=&daysago=&xp=1&xs=1&vl=&vh=&ocl=&och=&sic1=-1&sicl=100&sich=9999&grp=0&nfl=&nfh=&nil=&nih=&nol=&noh=&v2l=&v2h=&oc2l=&oc2h=&sortcol=0&cnt=100&page=1
An increase and not a dump.
This is very true. There has been a lot this company did not PR or come clean with and the investors paid dearly for it.
They don't need to seize computers if they know where they are looking. Andrew Left was known for committing fraud and being relatively sophisticated. So seizing his computers was deemed appropriate because of how he could be committing crimes possibly. Also seizures occur when the destruction of evidence is expected.
Jump over to CYTODYN. Nader is no sophisticated. We can see from the embarrassing Amarex emails he is not very smart about keeping his fraud relatively secret. DOJ just needs access to their servers and communications. If people coming forward have told the DOJ where evidence can be found the need to do a full forensic search isn't needed.
Most importantly CYDY could be downplaying things and left out the fact computers and documents were seized.